ID   BNL 1NG A.2
AC   CVCL_6372
DR   CLO; CLO_0002010
DR   ATCC; TIB-76
DR   BCRC; 60216
DR   Wikidata; Q54797672
RX   PubMed=723934;
RX   PubMed=9667749;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4383 ! BNL CL.2
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
RX   PubMed=723934; DOI=10.1038/276510a0;
RA   Patek P.Q., Collins J.L., Cohn M.;
RT   "Transformed cell lines susceptible or resistant to in vivo
RT   surveillance against tumorigenesis.";
RL   Nature 276:510-511(1978).
//
RX   PubMed=9667749; DOI=10.1093/carcin/19.6.1093;
RA   Gonzales A.J., Goldsworthy T.L., Fox T.R.;
RT   "Chemical transformation of mouse liver cells results in altered
RT   cyclin D-CDK protein complexes.";
RL   Carcinogenesis 19:1093-1102(1998).
//